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INTRODUCTION
Breast cancer is the most common cancer among American women, except for skin cancers. The chance of developing invasive breast cancer at some time in a woman's life is a little less than 1 in 8 (12%). The American Cancer Society's most recent estimates for breast cancer in the United States are for 2012 [1]:
• About 226,870 new cases of invasive breast cancer will be diagnosed in women.
• About 63,300 new cases of carcinoma in situ (CIS) will be diagnosed (CIS is non-invasive and is the earliest form of breast cancer).
• About 39,510 women will die from breast cancer The risk for breast cancer increases with age and several other factors which include genetic history, obesity, not or late child bearing, early menarche, and late menopause [2] .
The incidence of breast cancer (ductal carcinoma in situ (DC IS) and invasive breast cancer) has risen substantially over the past 20 years [3] [4] , in parallel with increasing use of screening mammography. But the female breast cancer incidence rates decreased by about 2% per year from 1999 to 2005. This decrease was seen only in women aged 50 or older, and may be due at least in part to the decline in use of hormone therapy after menopause.
Breast cancer is also the second leading cause of cancer death in women, exceeded only by lung cancer. The chance that breast cancer will be responsible for a woman's death is about 1 in 36 (about 3%). Death rates from breast cancer have been declining since about 1990, with larger decreases in women younger than 50. These decreases are believed to be the result of earlier detection through screening and increased awareness, as well as improved treatment.
Cancer-related organizations such as the American Medical Association, the American College of Obstetricians and Gynecologists (ACOG), and the American Cancer Society recommend that women age 40 and older have a mammogram every year.
The Health People 2010 (HP20 1 0) planed to have 70% of women over 40 years old with mammogram. But some states have not achieved the objective [5] . The breast cancer screening rate has been increasing steadily since the 1990s but fell slightly between 1999 and 2002 [6] . This drop in the screening rate raised the concern that breast cancer occurrence and mortality rates might increase. Moreover, despite the overall increase in the screening rate, disparities based on race, age, education, income or social class still exist in breast cancer screening [7] [8] [9] [10] . Understanding the strong association between demographic position and the breast cancer screening rate may provide insight into improving the screening rate.
Several studies in other countries have revealed disparities between population subgroups at each phase of breast cancer [11] [12] [13] . Although disparities in screening mammography have improved overall since the early 1990s, significant differences in screening persist among many medically underserved communities. Vulnerable populations such as racial/ethnic minorities, the elderly, and the poor are more likely to be uninsured and lack a usual source of care. Compared to their middle-class and wealthy counterparts, low-income women have the lowest rates of breast cancer screening, even when adjusted for race, ethnicity, and insurance status [14] [15] [16] . Low socioeconomic status (SES) is a consistent marker for mammography underuse;
All racial/ethnic minorities in the U.S. have been documented underutilization of preventive health services that reflect sociodemographic variables, cultural barriers, and health systems obstacles. National Health Interview Survey (NHIS) describes new immigrants as the latest subpopulation of women with low rates of mammography use.
Only 39.3% of women living in the U.S. for less than 10 years reported having a mammogram within the prior 2 years, in comparison to 64.7% of women living in the U.S. for 10 years or more and 71.3% of women born in the U.S. [17] Immigrants are disproportionately members of racial/ethnic minorities, making these women at particularly high risk for underuse of mammography. Besides, the black women in USA receive less mammography than white women even with similar use of primary care. A study showed black women were more likely to not undergo mammography (odds ratio [OR], 3.00 [95% CI, 2.41 to 3.75]) and to be given a diagnosis oflate-stage disease (OR, 2.49 [CI, 1.59 to 3.92] ) than white women [18] . Although some research suggests that this gap may be narrowing [19] , the difference in use of mammography between black women and white women persists. Having a regular provider or source of health care is the most important determinant of mammography use [20] [21] . Whites, younger women, and women with higher incomes and more education are consistently more likely to use mammography. Although the effect is more modest than that of the other factors, having insurance that covers the cost of mammography has been shown to increase the use of mammography. For both black and white women, greater mammography use was associated with more visits to a primary care physician. The deficit for black women persisted at each socioeconomic status, even after use of primary care was considered.
The number of primary care visits did less to "boost" mammography use for black women than for white women. Thus, although the number of visits made to a primary care physician does influence mammography use, it is not sufficient to overcome socioeconomic and regional differences in mammography use. These results suggest that the nature of primary care may vary within and among states and between black women and white women.
Age is another cause of disparities in mammography. Women aged 65 years and older comprise or.ly 14% of women in the United States, nearly half (47%) of breast cancer cases diagnosed annually and more than half (53%) of breast cancer mortality occurs in this age group [22] [23] . Despite increased risk and evidence suggesting that mammography's mortality benefits can extend to elderly populations, older women are less likely to be screened [24] [25] . There has been little research addressing whether mammography is effective in decreasing breast cancer mortality in these women. This is due, in part, to competing risks of death and limited life expectancy; although elderly women have the highest risk of breast cancer, they are actually more likely to die of cardiovascular disease than malignancy [26] . Conflicting recommendations by various organizations about the age to stop mammographic screening reflect the uncertainty about the benefits of screening mammography in older women [27] [28] [29] [30] [31] . Numerous studies verify that women age 70 and older have lower rates of mammography compared to those between 50 and 69 years of age [32] [33] .
Women who live in rural areas are the one of subgroups for under-screening.
Previous studies have suggested that women living in rural areas of the United States may use preventive health care services less frequently than women living in urban areas of the country [34] . Studies also have found that women living in rural areas are less likely than those living in urban areas to have had a recent mammogram or Papanicolau (Pap) test [35] [36] . Furthermore, women in rural areas of the United States have been found to have higher rates of breast carcinoma and late-stage disease than women in non-rural areas [37] . Possible explanations to account for the less frequent use of preventive services by rural women, compared with non-rural women include they are more likely to be uninsured, have a low household income, and be less educated; they are at particular risk of preventive care underutilization compared to women in non-rural regions. A research showed [38] that women residing in rural areas of the US are screened for breast cancer at a significantly lower rate than women in urban areas (66.7% vs. 75.4%). Many rural regions are characterized by longer distances between medical facilities and less availability of health services, subsequently limiting access to breast cancer screening [39] . Tn addition, studies suggest that screening disparities between rural and non-rural populations are more pronounced among minorities. For example, rural ethnic subgroups such as African-American and Native-American women have been found to receive less cancer screening than their non-rural counterparts [40] .
The United States may be farther from its national goals of screening mammography, particularly among underserved women. Over the past two decades, health agencies on the federal and state level have made efforts to increase mammography use through outreach programs to those underserved women. The disparities of mammography screen have been improved, but the significant differences persist in the patterns of mammography by race /ethnicity, age, demographic, socioeconomic, and health system variables. The cause of breast cancer disparities is comprehensive. A study must define and character the groups that have fewer screening.
Most previous studies have observed the differences among cross-sectional disparities factors. However, continued monitoring of population-based trends and variations in breast cancer screening use by demographic position is needed. This study assessed the difference in the breast cancer screen according to women vs. socioeconomic position and examined the trends in breast cancer screen by observing differences in age, health insurance system, and racial demographics over 10 years period. The study explores the various barriers to mammography, with special attention to the unique needs of different populations. Despite the heterogeneity of medically underserved women, many of the barriers are common to different populations and reflect limited access to health information and services.
CHAPTER II
DATA AND ANALYSIS METHODS
Data sources
The De-identified breast cancer screen data were taken from 2001-2010 by James Graham Brown Cancer Center. The subjects are civilian, non-institutionalized adults aged 18 older. The purpose is to find the trends and disparities of impact of mobile mammography on the diagnosis of breast cancer. The screen is performed at 236 locations in state of Kentucky. If any abnormal is found, a further exam like ultrasound or biopsy is performed. A total of22534 women enter the program and some of them take multiple screens, so make a total of 58231 screens within 10 years.
The data set includes 14 variables that are patient study number, Corporate or Partnership Clinic or Partnership Community, Age, Comp date, Hispanic(Hispanic Y, N, Unknown), Ethnic, CPT, CPT name, Assessment, Rec Desc (description),Pathology, pathology code, Insured or uninsured, lost to FlU. The purpose of the thesis is to identify the disparities of people who participates the mammography screen based on race, age, insurance system and residual area. So we limit our analysis to those key variables such as location, age-group, ethnic, and insured. "race" replacing "ethnic" includes 3 categorical data: "black", "white" and "other"; "Agegroup" replacing "age" has 4 data: "50-", "50-59", "60-69" and "70+". Among 58231 screens, 89 screens are with missing or mistaken information and removed for analysis. It makes a total of 58142 screens for the following statistical analysis. The data structure is present in Table 1. 2. Analysis methods SAS (V9.2) and SAS enterprise were used to analysis the De-identified breast cancer screen data. At first the analysis based on screen number was done. The proportion of the screens based on 4 age groups, 3 races, 3 insurance systems, and 3 screen locations from 2001-2010 is shown. The thesis also presents the disparities of screen frequency for different combinations and the disparities of pathology code based on age group, race,
insurance system, and screen locations. Chi-square test to check the association (HO: Independent). Secondly, the analysis based on participants was performed which includes odds ratio calculation, CMH tests to check the conditional independence, the follow-up study, etc. Pearson and Spearman correlation coefficients were calculated to check the association.
CHAPTER III Another important concern is the disparities of pathology results of screens based on different insurance system, age groups, and races. As mentioned before, if any abnormal was found during the screen, a further exam was performed such as biopsy or ultrasound. The code (pathology code) represents seven different pathology results. 0 = "No Biopsy", 1 = "Benign", 2 = "CYST ASPIRATION", 3 = "Negative", 4 = "High Risk", 5 ="INCONCLUSIVE", and 6 = "MALIGNANT". Table 3 shows the frequency and percentage under different pathology code for all age groups, races, and insurance systems. For code = 0, age group "50-", race = "white", and Insured = "uninsured" have the highest percent number, 39.63%, 63.92% and 39.25% ,respectively; For code = 6, age group "50-59", race = "white", and Insured = "uninsured" have the highest % like, 35.19%, 59.66% and 48.07% , respectively; It is partially due to the uneven percentage of people coming to screen (Table 2) . Besides, Chi-square tests were performed to test the association. For all three categorical variables, P values are less than 0.001, which provide strong evidence of an association between "code (pathology code)" and all other three categorical variables (age group/race/insured). Because majority of people do not need biopsy (code=O), only 961 women are diagnosed with the other codes. Chi-square tests also were performed and all P values are less than 0.05 «0.001 for "agegroup", 0.0174 for "race", <0.001 for "insured"), which conclude the same result. Figure 11 . Trenn of screen disparities on age group of each race at code=6 Figure 10 and 11 show the trend of disparities of age group with different race at code = 0 and 6. The highest and lowest frequencies for code= 0 are 13948 for "white" younger than 50, 243 for "other" older than 70; for code = 6, they are 52 for "white" aged 50-59, 1 for "other" aged 60-69. Figure 13 . Trend of screen disparities on age group of each insurance at code=6 Figure 12 -13 are the diagrams of trend of disparities of age group with different insurance at code = 0 and 6 respectively. For both codes, all the highest and lowest screen frequencies happened in categorical variable "Insured "= Uninsured. They are 10994 for women younger than 50 and 152 for women older than 70 at code=O; 52 for women aged 50-59 and 3 for women older than 70 at code = 6.
RESULTS
Although a total number of screen is 58142, actually only 22500 individuals participant the program. Because some women have multiple screens where different result might exist for each one, for each woman, only the case with maximum pathology code was chosen for analysis. The summary of patients is present as Table 4 . Table 4 shows white and black women are the majority (~90% of population), so next we focus our analysis on this part of population. We replace variable "Insured" with "Insurance", combine "Private insured" and "Public insured" into Insurance = "yes", and define "Uninsured" as Insurance = "No". We also change "Pathology_code" into "Pathology Jesult", and combine 0-3 into Pathology Jesult = "Negative" and 4-6 into Pathology Jesult = "Positive". There are 20342 women left for analysis. Tables 5-7 present the calculated odds ratios and their 95% confidence intervals. Table 5 shows age groups "50-" and "50-59" have odds ratio of 1.6686 and 1.8572 which means the odds of white people with insurance is <2 times of black people with insurance for those two age groups. Age group "70+" is opposite, the odds of white women with insurance is only 0.4 time of black women with insurance. No much difference was found in odds between black and white for age group "60-69". From table 6, the significant result is only for age group "70+", the odds ratio is 4.4, so the odds of white women with "Negative" pathology result is 4.4 times of black women. There is not much difference for other age groups. Table 7 is the odds ratio of InsurancelPathology JesuIt. The two non-significant age groups are "60-69" and "70+", for other age groups, the odds ratios are 2.26 for "50-", and 2.08 for "50-59". The odds of women with insurance "Yes"
having "Negative" pathology result is 2.26/2.08 times of the women with insurance "No" for age group "50-", "50-59" respectively. Tables 8 and 9 are the follow-up study. N is the number of screens for an individual. The maximum number that each person can take the screen from this data set is N=17. The majority (45%) only take screen once. About 19% of women take twice, Table 8 Summary of screen numbers for each agegroup/racelinsured r ----· -------- 1-3) ; the pattern of age group for three different insurance system are not the same. The pattern of "public insured" is opposite to "Private insured" and "Uninsured". The reason partially is that "Public insured" (medicare and medicaid) aralways issued to old women (Figures 4-6 ); All three different locations "corporate", "partnership clinic", and "partnership community" have similar trends for all age groups over the 10 years. As shown in Figures 7-9 , except few cases, it generally follows the rule:
the older, the fewer screens. The disparities of pathology results of screens based on different insurance system, age groups, and races have also been analyzed in this study (Table 3) . For code = 0, age group "50-", race = "white", and Insured = "uninsured" have the highest percent numbers, 39.63%, 63.92% and 39.25% , respectively under each categorical variable; For code = 6, age group "50-59", race = "white", and Insured = "uninsured" have the highest % like, 35.19%, 59.66% and 48.07%. Besides, Chi-square tests were performed to test the association. For all three categorical variables, P values are less than 0.001, which provide strong evidence of an association between "code (pathology code)" and all other three categorical variables "agegroup", "race", and "Insured". The trend studies are to check the patterns between race/insurance system of all age groups for each specific pathology code (Figures 1 0-13 ).
As mentioned before, there are 22534 individuals participant the program, the odds ratio analysis is done on white and black women only because they are the majority of participants (90%). some women have multiple screens with multiple pathology codes.
For each woman, only the case with maximum pathology code was chosen for odds ratio calculation. There are 20342 women left for analysis. The calculated odds ratios and their 95% confidence intervals are present in Tables 5-7 . Basically, for race/insurance, in age groups "50-", "50-59"and '70+', the odds of white people with insurance is 1.7, 1.9, and 0.4 times of black people with insurance respectively. No much difference in odds was found in age group "60-69". F or race/pathology_result, the significant result is only for age group "70+", the odds of white women with "Negative" pathology result is 4.4 times of black women with "Negative" pathology result. Besides, for insurance/pathology result, the odds of women with insurance "Yes" having "Negative" pathology result are 2.26 and 2.08 times of the women with insurance "Yes" having "Negative" pathology result for age group "50-" and "50-59". The follow-up study was performed based on 22500 women (34 of22534 with missing information). The maximum number that each person took the screen for this data set is 17. The majority (45%) only take screen once.
About 19% of women took twice, 12% took triple. Only one woman took 17 times.
Pearson and Spearman correlation coefficients were calculated to check the association. 
